1. Home
  2. AVDL vs MAGN Comparison

AVDL vs MAGN Comparison

Compare AVDL & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • MAGN
  • Stock Information
  • Founded
  • AVDL 2015
  • MAGN 1864
  • Country
  • AVDL Ireland
  • MAGN United States
  • Employees
  • AVDL N/A
  • MAGN N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • MAGN Paper
  • Sector
  • AVDL Health Care
  • MAGN Basic Materials
  • Exchange
  • AVDL Nasdaq
  • MAGN Nasdaq
  • Market Cap
  • AVDL 784.6M
  • MAGN 681.5M
  • IPO Year
  • AVDL 1996
  • MAGN N/A
  • Fundamental
  • Price
  • AVDL $8.03
  • MAGN $14.54
  • Analyst Decision
  • AVDL Strong Buy
  • MAGN Buy
  • Analyst Count
  • AVDL 7
  • MAGN 1
  • Target Price
  • AVDL $18.86
  • MAGN $24.00
  • AVG Volume (30 Days)
  • AVDL 1.1M
  • MAGN 499.6K
  • Earning Date
  • AVDL 05-07-2025
  • MAGN 05-07-2025
  • Dividend Yield
  • AVDL N/A
  • MAGN N/A
  • EPS Growth
  • AVDL N/A
  • MAGN N/A
  • EPS
  • AVDL N/A
  • MAGN N/A
  • Revenue
  • AVDL $169,117,000.00
  • MAGN $2,370,000,000.00
  • Revenue This Year
  • AVDL $50.53
  • MAGN $51.30
  • Revenue Next Year
  • AVDL $32.33
  • MAGN $4.20
  • P/E Ratio
  • AVDL N/A
  • MAGN N/A
  • Revenue Growth
  • AVDL 504.79
  • MAGN N/A
  • 52 Week Low
  • AVDL $6.38
  • MAGN $13.11
  • 52 Week High
  • AVDL $19.09
  • MAGN $26.78
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 54.47
  • MAGN N/A
  • Support Level
  • AVDL $6.38
  • MAGN N/A
  • Resistance Level
  • AVDL $8.22
  • MAGN N/A
  • Average True Range (ATR)
  • AVDL 0.48
  • MAGN 0.00
  • MACD
  • AVDL 0.11
  • MAGN 0.00
  • Stochastic Oscillator
  • AVDL 89.67
  • MAGN 0.00

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About MAGN Magnera Corporation Common Stock

Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.

Share on Social Networks: